Featured in Nikkei Sangyo ShimbunMakoto YamamotoFeb 8, 20231 min readWe are honored to have our nucleic acid platform featured in Nikkei Sangyo Shimbun, recognizing its innovative mechanism and therapeutic promise.「DNAでがん細胞 狙い撃ち 東大、免疫反応生かす核酸医薬」
Comments